Mannatech, Incorporated

NasdaqCM MTEX

Mannatech, Incorporated Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2024: USD 91.52 M

Mannatech, Incorporated Gross Profit is USD 91.52 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -10.20% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.

Mannatech, Incorporated Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 101.92 M, a -8.21% change year over year.
Mannatech, Incorporated Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 111.04 M, a -10.27% change year over year.
Mannatech, Incorporated Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 123.75 M, a 4.63% change year over year.
Mannatech, Incorporated Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 118.27 M, a -9.07% change year over year.

Key data

Date	Gross Profit	Operating Income	EBIT	EBITDA

NasdaqCM: MTEX

Mannatech, Incorporated

CEO	Mr. Landen Granvel Fredrick
IPO Date	Feb. 16, 1999
Location	United States
Headquarters	1410 Lakeside Parkway
Employees	213
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.

Key trends

Past 5 years